Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (17H06162, 16K15551, 17K18388, 17J09900)
Japan Agency for Medical Research and Development (16cm0106301h0002)
National Cancer Center (28-A-7)
Takeda Science Foundation
Eli Lilly and Company
Text and Data Mining valid from 2018-10-11
Received: 20 April 2018
Accepted: 5 September 2018
First Online: 11 October 2018
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of the National Cancer Center (2015–048 and 2016–029) and was conducted in accordance with international ethics guidelines, including the Declaration of Helsinki. We obtained written informed consent from all participants before sampling.
: No individual data were used in this study.
: Y. Togashi received honoraria from Eli Lilly Japan KK. KS received honoraria and grants from Eli Lilly Japan KK. No other disclosures are reported.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.